Gold-Lipid Hybrid Nanoparticles for Synergistic Treatment Using Radiation for Spatially and Temporally Specific Cancer Therapy

金脂混合纳米颗粒用于协同治疗，利用辐射进行空间和时间特异性癌症治疗

• 批准号: 406752
• 负责人: van Ballegooie Courtney E
• 金额: $ 7.65万
• 依托单位: BC Cancer, part of PHSA (Vancouver)
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2018
• 资助国家: 加拿大
• 起止时间: 2018-10-01 至 2021-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=406752&lang=en
• 关键词: Chemotherapy; Gold-Lipid Hybrid Liposomes; Improved Patient Outcomes; Inert Biocompatible Carrier Systems; Pancreatic Cancer; Spatially And Temporally Specific Cancer Therapies; Targeted Drug Delivery; Triggered Cancer Therapy; Tumor-Associated Macrophage

Many attempts have been made to modify the distribution of chemotherapy drugs within the body in order to concentrate their activity within the tumour. An effective strategy has been to sequester the drug in a non-reactive carrier which then selectively a

已经进行了许多尝试来改变化疗药物在体内的分布，以便将它们的活性集中在肿瘤内。一种有效的策略是将药物隔离在非反应性载体中，然后选择性地